HEADER HYDROLASE/HYDROLASE INHIBITOR 11-DEC-15 5FAP TITLE CTX-M-15 IN COMPLEX WITH FPI-1602 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-LACTAMASE; COMPND 3 CHAIN: B, A; COMPND 4 EC: 3.5.2.6; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 GENE: BLAUOE-1, BLA, BLA CTX-M-15, BLA_1, BLA_2, BLA_3, BLACTX-M-15, SOURCE 5 BLACTX-M15, CTX-M-15, ECONIH1_02760, ECONIH1_27135, ERS085368_04262, SOURCE 6 ERS085370_01802, ERS085377_05268, ERS139214_01914, ERS139238_04648, SOURCE 7 ERS139238_04652, ERS150880_04508, HUS2011_PI0012, PCTXM15_EC8_00003, SOURCE 8 SK84_05077, SK86_03319; SOURCE 9 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.M.KING,D.T.KING,S.FRENCH,E.BROUILLETTE,A.ASLI,A.N.ALEXANDER, AUTHOR 2 M.VUCKOVIC,S.N.MAITI,T.R.PARR,E.D.BROWN,F.MALOUIN,N.C.J.STRYNADKA, AUTHOR 3 G.D.WRIGHT REVDAT 5 27-SEP-23 5FAP 1 REMARK REVDAT 4 20-NOV-19 5FAP 1 REMARK REVDAT 3 20-SEP-17 5FAP 1 REMARK REVDAT 2 27-APR-16 5FAP 1 JRNL REVDAT 1 20-JAN-16 5FAP 0 JRNL AUTH A.M.KING,D.T.KING,S.FRENCH,E.BROUILLETTE,A.ASLI, JRNL AUTH 2 J.A.ALEXANDER,M.VUCKOVIC,S.N.MAITI,T.R.PARR,E.D.BROWN, JRNL AUTH 3 F.MALOUIN,N.C.STRYNADKA,G.D.WRIGHT JRNL TITL STRUCTURAL AND KINETIC CHARACTERIZATION OF JRNL TITL 2 DIAZABICYCLOOCTANES AS DUAL INHIBITORS OF BOTH JRNL TITL 3 SERINE-BETA-LACTAMASES AND PENICILLIN-BINDING PROTEINS. JRNL REF ACS CHEM.BIOL. V. 11 864 2016 JRNL REFN ESSN 1554-8937 JRNL PMID 26731698 JRNL DOI 10.1021/ACSCHEMBIO.5B00944 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0071 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.97 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 95.3 REMARK 3 NUMBER OF REFLECTIONS : 13713 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.189 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT : 761 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.77 REMARK 3 REFLECTION IN BIN (WORKING SET) : 964 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.25 REMARK 3 BIN R VALUE (WORKING SET) : 0.2700 REMARK 3 BIN FREE R VALUE SET COUNT : 59 REMARK 3 BIN FREE R VALUE : 0.3380 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3878 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 48 REMARK 3 SOLVENT ATOMS : 85 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.48 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.36000 REMARK 3 B22 (A**2) : 0.46000 REMARK 3 B33 (A**2) : -0.15000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.13000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.343 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.930 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.889 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3986 ; 0.010 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3884 ; 0.000 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5410 ; 1.256 ; 1.974 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8924 ; 3.879 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 514 ; 5.694 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 162 ;42.442 ;24.568 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 676 ;16.674 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 30 ;16.048 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 636 ; 0.092 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4550 ; 0.013 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 848 ; 0.010 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2068 ; 2.040 ; 2.608 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2067 ; 2.041 ; 2.608 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2578 ; 3.182 ; 3.909 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2579 ; 3.181 ; 3.909 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1918 ; 2.674 ; 2.907 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1919 ; 2.673 ; 2.907 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2829 ; 4.297 ; 4.241 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4126 ; 5.487 ;20.298 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4122 ; 5.486 ;20.302 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5FAP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-DEC-15. REMARK 100 THE DEPOSITION ID IS D_1000216268. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUL-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14478 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 30.970 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.4 REMARK 200 DATA REDUNDANCY : 2.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4HBT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.81 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M AMMONIUM SULFATE, 0.1M MES PH6.5, REMARK 280 30% PEG5K MONOMETHYL ETHER, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 30.91500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN B 26 REMARK 465 THR B 27 REMARK 465 ALA B 28 REMARK 465 GLY B 287 REMARK 465 LEU B 288 REMARK 465 GLN A 26 REMARK 465 THR A 27 REMARK 465 ALA A 28 REMARK 465 GLY A 287 REMARK 465 LEU A 288 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER B 70 CAM 602 B 301 1.01 REMARK 500 OG SER B 70 OAN 602 B 301 1.83 REMARK 500 OG SER B 70 N 602 B 301 2.11 REMARK 500 CB SER A 70 CAM 602 A 301 2.13 REMARK 500 OG SER A 70 N 602 A 301 2.14 REMARK 500 OG SER A 70 OAN 602 A 301 2.19 REMARK 500 CB SER B 70 CAM 602 B 301 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS B 69 -139.15 60.56 REMARK 500 SER B 220 -117.20 -104.43 REMARK 500 CYS A 69 -132.60 60.83 REMARK 500 ASN A 89 31.82 -99.51 REMARK 500 VAL A 103 -144.51 -132.20 REMARK 500 ASN A 106 63.60 -150.53 REMARK 500 SER A 220 -117.27 -101.02 REMARK 500 ASP A 245 125.81 -171.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLU B 87 PRO B 88 -148.26 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 602 B 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5FAO RELATED DB: PDB REMARK 900 RELATED ID: 5FA7 RELATED DB: PDB REMARK 900 RELATED ID: 5FAQ RELATED DB: PDB REMARK 900 RELATED ID: 5FAS RELATED DB: PDB REMARK 900 RELATED ID: 5FAT RELATED DB: PDB DBREF 5FAP B 26 288 UNP Q9EXV5 Q9EXV5_ECOLX 29 291 DBREF 5FAP A 26 288 UNP Q9EXV5 Q9EXV5_ECOLX 29 291 SEQRES 1 B 263 GLN THR ALA ASP VAL GLN GLN LYS LEU ALA GLU LEU GLU SEQRES 2 B 263 ARG GLN SER GLY GLY ARG LEU GLY VAL ALA LEU ILE ASN SEQRES 3 B 263 THR ALA ASP ASN SER GLN ILE LEU TYR ARG ALA ASP GLU SEQRES 4 B 263 ARG PHE ALA MET CYS SER THR SER LYS VAL MET ALA ALA SEQRES 5 B 263 ALA ALA VAL LEU LYS LYS SER GLU SER GLU PRO ASN LEU SEQRES 6 B 263 LEU ASN GLN ARG VAL GLU ILE LYS LYS SER ASP LEU VAL SEQRES 7 B 263 ASN TYR ASN PRO ILE ALA GLU LYS HIS VAL ASN GLY THR SEQRES 8 B 263 MET SER LEU ALA GLU LEU SER ALA ALA ALA LEU GLN TYR SEQRES 9 B 263 SER ASP ASN VAL ALA MET ASN LYS LEU ILE ALA HIS VAL SEQRES 10 B 263 GLY GLY PRO ALA SER VAL THR ALA PHE ALA ARG GLN LEU SEQRES 11 B 263 GLY ASP GLU THR PHE ARG LEU ASP ARG THR GLU PRO THR SEQRES 12 B 263 LEU ASN THR ALA ILE PRO GLY ASP PRO ARG ASP THR THR SEQRES 13 B 263 SER PRO ARG ALA MET ALA GLN THR LEU ARG ASN LEU THR SEQRES 14 B 263 LEU GLY LYS ALA LEU GLY ASP SER GLN ARG ALA GLN LEU SEQRES 15 B 263 VAL THR TRP MET LYS GLY ASN THR THR GLY ALA ALA SER SEQRES 16 B 263 ILE GLN ALA GLY LEU PRO ALA SER TRP VAL VAL GLY ASP SEQRES 17 B 263 LYS THR GLY SER GLY GLY TYR GLY THR THR ASN ASP ILE SEQRES 18 B 263 ALA VAL ILE TRP PRO LYS ASP ARG ALA PRO LEU ILE LEU SEQRES 19 B 263 VAL THR TYR PHE THR GLN PRO GLN PRO LYS ALA GLU SER SEQRES 20 B 263 ARG ARG ASP VAL LEU ALA SER ALA ALA LYS ILE VAL THR SEQRES 21 B 263 ASP GLY LEU SEQRES 1 A 263 GLN THR ALA ASP VAL GLN GLN LYS LEU ALA GLU LEU GLU SEQRES 2 A 263 ARG GLN SER GLY GLY ARG LEU GLY VAL ALA LEU ILE ASN SEQRES 3 A 263 THR ALA ASP ASN SER GLN ILE LEU TYR ARG ALA ASP GLU SEQRES 4 A 263 ARG PHE ALA MET CYS SER THR SER LYS VAL MET ALA ALA SEQRES 5 A 263 ALA ALA VAL LEU LYS LYS SER GLU SER GLU PRO ASN LEU SEQRES 6 A 263 LEU ASN GLN ARG VAL GLU ILE LYS LYS SER ASP LEU VAL SEQRES 7 A 263 ASN TYR ASN PRO ILE ALA GLU LYS HIS VAL ASN GLY THR SEQRES 8 A 263 MET SER LEU ALA GLU LEU SER ALA ALA ALA LEU GLN TYR SEQRES 9 A 263 SER ASP ASN VAL ALA MET ASN LYS LEU ILE ALA HIS VAL SEQRES 10 A 263 GLY GLY PRO ALA SER VAL THR ALA PHE ALA ARG GLN LEU SEQRES 11 A 263 GLY ASP GLU THR PHE ARG LEU ASP ARG THR GLU PRO THR SEQRES 12 A 263 LEU ASN THR ALA ILE PRO GLY ASP PRO ARG ASP THR THR SEQRES 13 A 263 SER PRO ARG ALA MET ALA GLN THR LEU ARG ASN LEU THR SEQRES 14 A 263 LEU GLY LYS ALA LEU GLY ASP SER GLN ARG ALA GLN LEU SEQRES 15 A 263 VAL THR TRP MET LYS GLY ASN THR THR GLY ALA ALA SER SEQRES 16 A 263 ILE GLN ALA GLY LEU PRO ALA SER TRP VAL VAL GLY ASP SEQRES 17 A 263 LYS THR GLY SER GLY GLY TYR GLY THR THR ASN ASP ILE SEQRES 18 A 263 ALA VAL ILE TRP PRO LYS ASP ARG ALA PRO LEU ILE LEU SEQRES 19 A 263 VAL THR TYR PHE THR GLN PRO GLN PRO LYS ALA GLU SER SEQRES 20 A 263 ARG ARG ASP VAL LEU ALA SER ALA ALA LYS ILE VAL THR SEQRES 21 A 263 ASP GLY LEU HET 602 B 301 24 HET 602 A 301 24 HETNAM 602 [[(3~{R},6~{S})-6-[(AZETIDIN-3-YLCARBONYLAMINO) HETNAM 2 602 CARBAMOYL]-1-METHANOYL-PIPERIDIN-3-YL]AMINO] HYDROGEN HETNAM 3 602 SULFATE FORMUL 3 602 2(C11 H19 N5 O7 S) FORMUL 5 HOH *85(H2 O) HELIX 1 AA1 ASP B 29 GLY B 42 1 14 HELIX 2 AA2 CYS B 69 THR B 71 5 3 HELIX 3 AA3 SER B 72 GLU B 87 1 16 HELIX 4 AA4 ASN B 89 ASN B 92 5 4 HELIX 5 AA5 LYS B 98 LEU B 102 5 5 HELIX 6 AA6 ILE B 108 HIS B 112 5 5 HELIX 7 AA7 LEU B 119 TYR B 129 1 11 HELIX 8 AA8 ASP B 131 GLY B 143 1 13 HELIX 9 AA9 GLY B 144 GLY B 156 1 13 HELIX 10 AB1 PRO B 167 THR B 171 5 5 HELIX 11 AB2 SER B 182 LEU B 195 1 14 HELIX 12 AB3 GLY B 200 GLY B 213 1 14 HELIX 13 AB4 SER B 220 LEU B 225 5 6 HELIX 14 AB5 GLY B 239 GLY B 241 5 3 HELIX 15 AB6 ARG B 273 ASP B 286 1 14 HELIX 16 AB7 VAL A 30 GLY A 42 1 13 HELIX 17 AB8 CYS A 69 THR A 71 5 3 HELIX 18 AB9 SER A 72 SER A 84 1 13 HELIX 19 AC1 GLU A 85 SER A 86 5 2 HELIX 20 AC2 GLU A 87 LEU A 91 5 5 HELIX 21 AC3 ILE A 108 VAL A 113 5 6 HELIX 22 AC4 LEU A 119 TYR A 129 1 11 HELIX 23 AC5 ASP A 131 GLY A 143 1 13 HELIX 24 AC6 GLY A 144 LEU A 155 1 12 HELIX 25 AC7 PRO A 167 THR A 171 5 5 HELIX 26 AC8 SER A 182 LEU A 195 1 14 HELIX 27 AC9 GLY A 200 GLY A 213 1 14 HELIX 28 AD1 ILE A 221 LEU A 225 5 5 HELIX 29 AD2 GLY A 239 GLY A 241 5 3 HELIX 30 AD3 ARG A 273 ASP A 286 1 14 SHEET 1 AA1 5 GLN B 57 TYR B 60 0 SHEET 2 AA1 5 ARG B 44 ASN B 51 -1 N VAL B 47 O TYR B 60 SHEET 3 AA1 5 LEU B 257 THR B 264 -1 O TYR B 262 N GLY B 46 SHEET 4 AA1 5 THR B 242 TRP B 250 -1 N ALA B 247 O LEU B 259 SHEET 5 AA1 5 VAL B 230 GLY B 238 -1 N GLY B 236 O ASN B 244 SHEET 1 AA2 2 PHE B 66 ALA B 67 0 SHEET 2 AA2 2 THR B 180 THR B 181 -1 O THR B 181 N PHE B 66 SHEET 1 AA3 2 ARG B 94 GLU B 96 0 SHEET 2 AA3 2 THR B 116 SER B 118 -1 O MET B 117 N VAL B 95 SHEET 1 AA4 5 GLN A 57 TYR A 60 0 SHEET 2 AA4 5 ARG A 44 ASN A 51 -1 N VAL A 47 O TYR A 60 SHEET 3 AA4 5 LEU A 257 THR A 264 -1 O TYR A 262 N GLY A 46 SHEET 4 AA4 5 THR A 243 TRP A 250 -1 N ILE A 249 O LEU A 257 SHEET 5 AA4 5 VAL A 230 SER A 237 -1 N VAL A 230 O TRP A 250 SHEET 1 AA5 2 PHE A 66 ALA A 67 0 SHEET 2 AA5 2 THR A 180 THR A 181 -1 O THR A 181 N PHE A 66 SHEET 1 AA6 2 ARG A 94 ILE A 97 0 SHEET 2 AA6 2 GLY A 115 SER A 118 -1 O GLY A 115 N ILE A 97 LINK OG SER A 70 CAM 602 A 301 1555 1555 1.21 CISPEP 1 GLU B 166 PRO B 167 0 1.74 CISPEP 2 GLU A 166 PRO A 167 0 7.20 SITE 1 AC1 9 SER B 70 ASN B 104 SER B 130 ASN B 132 SITE 2 AC1 9 PRO B 167 ASN B 170 THR B 235 GLY B 236 SITE 3 AC1 9 SER B 237 CRYST1 63.120 61.830 73.070 90.00 103.98 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015843 0.000000 0.003944 0.00000 SCALE2 0.000000 0.016173 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014103 0.00000